Saturday, December 6, 2025

Creating liberating content

Introducing deBridge Finance: Bridging...

In the dynamic landscape of decentralized finance (DeFi), innovation is a constant,...

Hyperliquid Airdrop: Everything You...

The Hyperliquid blockchain is redefining the crypto space with its lightning-fast Layer-1 technology,...

Unlock the Power of...

Join ArcInvest Today: Get $250 in Bitcoin and a 30% Deposit Bonus to...

Claim Your Hyperliquid Airdrop...

How to Claim Your Hyperliquid Airdrop: A Step-by-Step Guide to HYPE Tokens The Hyperliquid...
HomeSportsThe TAD dismisses...

The TAD dismisses the appeal of Nairo Quintana

Euskaraz irakurri: TADak ez du onartu Nairo Quintanaren helegitea

The Court of Arbitration for Sport (TAD) has dismissed the appeal of Colombian cyclist Nairo Quintana against the sanction imposed by the International Cycling Union (UCI)that disqualified him from the last Tour de France for violating their medical regulations.

The UCI made this decision after analyzes of two blood samples provided by the cyclist on July 8 and 13 during the 2022 Tour de France revealed the presence of tramadol and its two main metabolites.

After the hearing of the case held on October 12, the TAD panel resolved that the UCI’s ban on tramadol in competition is due to medical reasons and not to doping reasons and, therefore, is within the powers and jurisdiction of the body.

The panel also concluded that the scientific evidence confirms that Nairo Quintana’s samples contained both tramadol and its two metabolites and on this basis determined that the contested decision should be upheldfor which the cyclist’s appeal was dismissed.

The UCI announced on August 17 the disqualification of Quintana from the last Tour, in which he finished sixth, for violating its medical regulations and imposed a fine of 5,000 Swiss francs, after which the runner decided to resort to the TAD and resigned to participate in the Vuelta a Españaalthough the regulations allowed him to compete in it.


Source: Eitb

Get notified whenever we post something new!

Continue reading

8 out of 10 asthmatics did not receive the recommended two-day follow-up visit

The study found that more than 8 in 10 patients with asthma did not receive standard care, and the situation was even worse for black patients. Just 18 percent of asthma patients admitted to hospital saw their GP within the...

Which health app is better? We tried Zoe, Fast 800 and MyFitnessPal.

Whether it's a pedometer, a sleep tracker, or a doctor's appointment system, chances are you have a health app on your smartphone. Health and wellness apps are big business: the market was valued at around €36 billion in 2022...

The Covid JN.1 variant continues to spread as UK case numbers approach record levels.

The highly contagious JN.1 subvariant continues to spread across the UK and is now responsible for almost two thirds of all new Covid cases, figures show. The number of JN.1 infections has risen sharply in recent weeks, from 4 percent...